Clinical trials
Phase 3 Demyelinating Diseases trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2006 | 1 |
| 2007 | 2 |
| 2011 | 1 |
| 2015 | 2 |
| 2019 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Acorda Therapeutics | 4 |
| Alexion Pharmaceuticals, Inc. | 2 |
| Baxalta now part of Shire | 1 |
| University of British Columbia | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Demyelinating Diseases | 8 |
| Multiple Sclerosis | 5 |
| Autoimmune Diseases | 2 |
| Autoimmune Diseases of the Nervous System | 2 |
| Immune System Diseases | 2 |
| Myelitis, Transverse | 2 |
| Nervous System Diseases | 2 |
| Neuromyelitis Optica | 2 |
| Optic Neuritis | 2 |
| Recurrence | 2 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.